• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一组肝纤维化生化标志物对非酒精性脂肪性肝炎患者的诊断价值。

Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.

作者信息

Lesmana C Rinaldi A, Hasan Irsan, Budihusodo Unggul, Gani Rino A, Krisnuhoni Ening, Akbar Nurul, Lesmana Laurentius A

机构信息

Department of Internal Medicine, Division of Hepatology, University of Indonesia, Jakarta, Indonesia.

出版信息

J Dig Dis. 2009 Aug;10(3):201-6. doi: 10.1111/j.1751-2980.2009.00386.x.

DOI:10.1111/j.1751-2980.2009.00386.x
PMID:19659788
Abstract

OBJECTIVE

The objectives of this study were to investigate the use of non-invasive biochemical markers to evaluate the severity of liver fibrosis in patients with non-alcoholic steatohepatitis (NASH).

METHODS

This was a cross-sectional study of patients with histopathologically confirmed NASH between January 2005 and December 2006. The patients' characteristics were recorded and the body mass index was calculated for each patient. All patients underwent ultrasound-guided liver biopsy and a fibrosis assessment was performed using the Brunt criteria. The non-invasive laboratory markers measured were insulin resistance, tumor necrosis factor (TNF-alpha), type IV collagen and hyaluronic acid (HA).

RESULTS

Thirty patients were recruited, of whom 18 (60%) were men. Their mean age was 45 +/- 13.9 (18-71) years. About 83% of patients had fibrosis stage 1-2. In bivariate analysis, age, TNF-alpha and type IV collagen concentrations showed a weak but significant correlation with the fibrosis stage. When the patients were grouped into mild fibrosis (stages 1-2) and advanced fibrosis (stages 3-4), the mean concentrations of HA and type IV collagen were significantly higher in those with advanced fibrosis than those with mild fibrosis (180.8 +/- 49.63 vs 543.6 +/- 360.45 ng/mL; for HA; P = 0.026 and 125.3 +/- 32.11 vs 288.0 +/- 171.22 ng/mL for type IV collagen; P = 0.010).

CONCLUSION

Our study showed that the degree of liver fibrosis was significantly correlated with age, TNF-alpha and type IV collagen concentrations. The level of HA and type IV collagen could differentiate between mild (F1-2) and advanced fibrosis (F3-4).

摘要

目的

本研究的目的是调查使用非侵入性生化标志物评估非酒精性脂肪性肝炎(NASH)患者肝纤维化严重程度的情况。

方法

这是一项对2005年1月至2006年12月间组织病理学确诊为NASH的患者进行的横断面研究。记录患者的特征,并计算每位患者的体重指数。所有患者均接受超声引导下肝活检,并使用布伦特标准进行纤维化评估。所测量的非侵入性实验室标志物包括胰岛素抵抗、肿瘤坏死因子(TNF-α)、IV型胶原和透明质酸(HA)。

结果

招募了30名患者,其中18名(60%)为男性。他们的平均年龄为45±13.9(18 - 71)岁。约83%的患者纤维化分期为1 - 2期。在双变量分析中,年龄、TNF-α和IV型胶原浓度与纤维化分期呈弱但显著的相关性。当将患者分为轻度纤维化(1 - 2期)和重度纤维化(3 - 4期)时,重度纤维化患者的HA和IV型胶原平均浓度显著高于轻度纤维化患者(HA:180.8±49.63 vs 543.6±360.45 ng/mL;P = 0.026;IV型胶原:125.3±32.11 vs 288.0±171.22 ng/mL;P = 0.010)。

结论

我们的研究表明,肝纤维化程度与年龄、TNF-α和IV型胶原浓度显著相关。HA和IV型胶原水平可区分轻度(F1 - 2)和重度纤维化(F3 - 4)。

相似文献

1
Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.一组肝纤维化生化标志物对非酒精性脂肪性肝炎患者的诊断价值。
J Dig Dis. 2009 Aug;10(3):201-6. doi: 10.1111/j.1751-2980.2009.00386.x.
2
[The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].[血清透明质酸、IV型胶原7S结构域及AST/ALT比值作为慢性乙型肝炎和肝硬化患者肝纤维化标志物的诊断价值]
Taehan Kan Hakhoe Chi. 2003 Jun;9(2):79-88.
3
[Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].[IV型胶原和透明质酸在丙型肝炎患者血清中对肝纤维化分期的诊断意义]
Ter Arkh. 2005;77(4):50-5.
4
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者血清透明质酸、肿瘤坏死因子-α和白细胞介素-8水平
Hepatogastroenterology. 2005 Sep-Oct;52(65):1549-53.
5
Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH).血清肝纤维化标志物在非酒精性脂肪性肝炎(NASH)诊断中的应用价值。
Hepatogastroenterology. 2006 Sep-Oct;53(71):678-81.
6
The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.血清纤维化标志物水平及肝纤维化的形态计量学定量测量。
Hepatobiliary Pancreat Dis Int. 2002 May;1(2):202-6.
7
Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.血清脂联素水平、HOMA-IR及血清IV型胶原7S水平联合评估对预测非酒精性脂肪性肝炎早期阶段的效用。
Am J Gastroenterol. 2007 Sep;102(9):1931-8. doi: 10.1111/j.1572-0241.2007.01322.x. Epub 2007 May 19.
8
Serum hyaluronic acid as a marker of hepatic fibrosis.血清透明质酸作为肝纤维化的标志物。
J Coll Physicians Surg Pak. 2007 Jun;17(6):323-6.
9
Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).脂肪激素作为非酒精性脂肪性肝炎(NASH)患者的预后标志物。
J Physiol Pharmacol. 2009 Oct;60 Suppl 3:71-5.
10
[Diagnostic value of five serum markers for liver fibrosis].[五种血清标志物对肝纤维化的诊断价值]
Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):148-50.

引用本文的文献

1
Circulating type IV collagen 7S concentrations are associated with left atrial remodeling indices in patients with atrial fibrillation.循环IV型胶原7S浓度与心房颤动患者的左心房重构指标相关。
J Int Med Res. 2025 Feb;53(2):3000605251314832. doi: 10.1177/03000605251314832.
2
Serologic Biomarkers for Hepatic Fibrosis in Obese Children with Nonalcoholic Steatohepatitis.肥胖非酒精性脂肪性肝炎儿童肝纤维化的血清学生物标志物
Pediatr Gastroenterol Hepatol Nutr. 2024 Jul;27(4):236-245. doi: 10.5223/pghn.2024.27.4.236. Epub 2024 Jul 8.
3
Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice.
五味子乙素通过在糖尿病小鼠中抗炎激活改善非酒精性肝病。
Drug Dev Res. 2022 May;83(3):735-744. doi: 10.1002/ddr.21905. Epub 2021 Dec 19.
4
Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease.多维度生物标志物分析,包括非酒精性脂肪性肝病的线粒体应激指标。
Gut Liver. 2022 Mar 15;16(2):171-189. doi: 10.5009/gnl210106.
5
Current treatment paradigms and emerging therapies for NAFLD/NASH.NAFLD/NASH 的现行治疗模式和新兴疗法。
Front Biosci (Landmark Ed). 2021 Jan 1;26(2):206-237. doi: 10.2741/4892.
6
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.代谢性炎症在非酒精性脂肪性肝病中作为肝纤维化的启动因素。
World J Gastroenterol. 2020 May 7;26(17):1993-2011. doi: 10.3748/wjg.v26.i17.1993.
7
Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice.长期高脂饮食喂养会促进小鼠非酒精性脂肪性肝病的发展并改变其肠道微生物群。
World J Hepatol. 2019 Aug 27;11(8):619-637. doi: 10.4254/wjh.v11.i8.619.
8
A new method to induce nonalcoholic steatohepatitis (NASH) in mice.一种诱导小鼠非酒精性脂肪性肝炎(NASH)的新方法。
BMC Gastroenterol. 2019 Jul 15;19(1):125. doi: 10.1186/s12876-019-1041-x.
9
The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.肠促胰素增强剂西他列汀可加剧高胆固醇饮食喂养大鼠肝脏炎症标志物的表达。
Inflamm Res. 2019 Jul;68(7):581-595. doi: 10.1007/s00011-019-01243-x. Epub 2019 May 9.
10
The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an Model of Non-Alcoholic Fatty Liver Disease Progression.营养保健品水飞蓟宾可对抗非酒精性脂肪性肝病进展模型中的脂质过度积累和持续氧化应激。
Front Nutr. 2017 Sep 19;4:42. doi: 10.3389/fnut.2017.00042. eCollection 2017.